3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Sarcoma
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Leukemia, Biphenotypic, Acute
2
Ganglioneuroblastoma
2
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Degradation of Top2b and Top2a in Human by Dexrazoxane
1
Cardiotoxicity
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
Magnetic Resonance Spectroscopy
8
Specimen Handling
7
Biopsy
6
X-Rays
5
Phantoms, Imaging
5
Temozolomide
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Carboplatin
4
selpercatinib
3
larotrectinib
3
Topotecan
3
Etoposide
3
Cyclophosphamide
3
Cisplatin
3
Automobiles
3
tazemetostat
2
pembrolizumab
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Vincristine
2
Surveys and Questionnaires
2
Radiotherapy
2
Radiosurgery
2
Radiation
2
Positron-Emission Tomography
2
Paclitaxel
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Dexrazoxane
×
1 year
×
Clear all
No trials found.